Clinical implications of the BRAVO and CRUISE trials: How should physicians apply this new information in their treatment of CRVO and BRVO?

Retina Today

Volumn , Issue APRIL, 2010, Pages 38-40

  Brown, David M ^a  

^a HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79952991352     PISSN: None     EISSN: 18250572     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Klein R, Moss SE, Meuer SM, Klein BE. The 15-year cumulative incidence of retinal vein occlusion: the Beaver Dam Eye Study. Arch Ophthalmol. 2008;126(4):513-518.
2. The Central Vein Occlusion Study Group: Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion. Ophthalmology. 1995;102:1425-1433.
3. The Branch Vein Occlusion Study Group: Argon laser photocoagulation for macula edema in branch vein occlusion. Am J Ophthalmol. 1984;98:271-282.
4. Aiello LP, Avery RL, Arrigg PG, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med. 1994;331(22):1480-1487.
5. Campochiaro PA. Safety and efficacy of intravitreal ranibizumab (Lucentis) in patients with macular edema secondary to branch retinal vein occlusion: The BRAVO Study. Paper presented at: Retina Congress 2009; October 4, 2009; New York, NY.
6. Brown DM. Safety and efficacy of intravitreal ranibizumab (Lucentis) in patients with macular edema secondary to central retinal vein occlusion: The CRUISE Study. Paper presented at: Retina Congress 2009; October 4, 2009; New York, NY.
7. American Society of Retina Specialists Annual Preferences and Trends Survey, 2009. http://www.asrs.org; access for members only.
8. Scott IU, Ip MS, VanVeldhuisen PC, et al; SCORE Study Research Group. A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 6. Arch Ophthalmol. 2009;127(9):1115-1128.